356 related articles for article (PubMed ID: 11301190)
21. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3.
Heemskerk MH; Blom B; Nolan G; Stegmann AP; Bakker AQ; Weijer K; Res PC; Spits H
J Exp Med; 1997 Nov; 186(9):1597-602. PubMed ID: 9348318
[TBL] [Abstract][Full Text] [Related]
22. Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15.
McCullar V; Oostendorp R; Panoskaltsis-Mortari A; Yun G; Lutz CT; Wagner JE; Miller JS
Exp Hematol; 2008 May; 36(5):598-608. PubMed ID: 18295962
[TBL] [Abstract][Full Text] [Related]
23. Loss of CD38 antigen on CD34+CD38+ cells during short-term culture.
von Laer D; Corovic A; Vogt B; Fehse B; Roscher S; Rimek A; Baum C; Ostertag W
Leukemia; 2000 May; 14(5):947-8. PubMed ID: 10803533
[No Abstract] [Full Text] [Related]
24. Positive and negative roles of the trans-acting T cell factor-1 for the acquisition of distinct Ly-49 MHC class I receptors by NK cells.
Kunz B; Held W
J Immunol; 2001 May; 166(10):6181-7. PubMed ID: 11342639
[TBL] [Abstract][Full Text] [Related]
25. High-efficiency retroviral transduction of fetal liver CD38-CD34++ cells: implications for in utero and ex utero gene therapy.
Ohkubo T; Bárcena A; Smith CA; Harrison MR; Muench MO
Fetal Diagn Ther; 2001; 16(5):299-307. PubMed ID: 11509853
[TBL] [Abstract][Full Text] [Related]
26. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
27. CD34+CD38dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells.
Res P; Martínez-Cáceres E; Cristina Jaleco A; Staal F; Noteboom E; Weijer K; Spits H
Blood; 1996 Jun; 87(12):5196-206. PubMed ID: 8652833
[TBL] [Abstract][Full Text] [Related]
28. Initiation and limitation of Ly-49A NK cell receptor acquisition by T cell factor-1.
Ioannidis V; Kunz B; Tanamachi DM; Scarpellino L; Held W
J Immunol; 2003 Jul; 171(2):769-75. PubMed ID: 12847244
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor.
Miller JS; Alley KA; McGlave P
Blood; 1994 May; 83(9):2594-601. PubMed ID: 7513206
[TBL] [Abstract][Full Text] [Related]
30. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38- hematopoietic stem cells.
Huang S; Terstappen LW
Blood; 1994 Mar; 83(6):1515-26. PubMed ID: 7510144
[TBL] [Abstract][Full Text] [Related]
31. Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia.
George AA; Franklin J; Kerkof K; Shah AJ; Price M; Tsark E; Bockstoce D; Yao D; Hart N; Carcich S; Parkman R; Crooks GM; Weinberg K
Blood; 2001 Jun; 97(12):3925-30. PubMed ID: 11389036
[TBL] [Abstract][Full Text] [Related]
32. Expression of novel surface antigens on early hematopoietic cells.
Bühring HJ; Seiffert M; Bock TA; Scheding S; Thiel A; Scheffold A; Kanz L; Brugger W
Ann N Y Acad Sci; 1999 Apr; 872():25-38; discussion 38-9. PubMed ID: 10372108
[TBL] [Abstract][Full Text] [Related]
33. In vitro identification of single CD34+CD38- cells with both lymphoid and myeloid potential.
Hao QL; Smogorzewska EM; Barsky LW; Crooks GM
Blood; 1998 Jun; 91(11):4145-51. PubMed ID: 9596660
[TBL] [Abstract][Full Text] [Related]
34. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins.
Phillips JH; Hori T; Nagler A; Bhat N; Spits H; Lanier LL
J Exp Med; 1992 Apr; 175(4):1055-66. PubMed ID: 1372642
[TBL] [Abstract][Full Text] [Related]
35. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
Cooper MA; Fehniger TA; Turner SC; Chen KS; Ghaheri BA; Ghayur T; Carson WE; Caligiuri MA
Blood; 2001 May; 97(10):3146-51. PubMed ID: 11342442
[TBL] [Abstract][Full Text] [Related]
36. Hematopoietic origin of human natural killer (NK) cells: generation from immature progenitors.
Silva MR; Kessler S; Ascensao JL
Pathobiology; 1993; 61(5-6):247-55. PubMed ID: 7507682
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
38. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.
Danet GH; Lee HW; Luongo JL; Simon MC; Bonnet DA
Exp Hematol; 2001 Dec; 29(12):1465-73. PubMed ID: 11750106
[TBL] [Abstract][Full Text] [Related]
39. Efficient retrovirus-mediated gene transfer to transplantable human bone marrow cells in the absence of fibronectin.
Hennemann B; Oh IH; Chuo JY; Kalberer CP; Schley PD; Rose-John S; Humphries RK; Eaves CJ
Blood; 2000 Oct; 96(7):2432-9. PubMed ID: 11001895
[TBL] [Abstract][Full Text] [Related]
40. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2.
Ikawa T; Fujimoto S; Kawamoto H; Katsura Y; Yokota Y
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5164-9. PubMed ID: 11296270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
